These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 35774845)

  • 1. Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.
    Zhang JJ; Song CG; Dai JM; Li L; Yang XM; Chen ZN
    MedComm (2020); 2022 Sep; 3(3):e148. PubMed ID: 35774845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid system: a promising target for future smoking cessation medications.
    Norman H; D'Souza MS
    Psychopharmacology (Berl); 2017 May; 234(9-10):1371-1394. PubMed ID: 28285326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VTA μ-opioidergic neurons facilitate low sociability in protracted opioid withdrawal.
    Jo AY; Xie Y; Rodrigues A; Sandoval Ortega RA; Creasy KT; Beier KT; Blendy JA; Corder G
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
    Popova D; Desai N; Blendy JA; Pang ZP
    J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-Opioid Receptors Expressed in Glutamatergic Neurons are Essential for Morphine Withdrawal.
    Zhang XY; Li Q; Dong Y; Yan W; Song K; Lin YQ; Sun YG
    Neurosci Bull; 2020 Oct; 36(10):1095-1106. PubMed ID: 32451910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. μ-Opioid Receptors on Distinct Neuronal Populations Mediate Different Aspects of Opioid Reward-Related Behaviors.
    Severino AL; Mittal N; Hakimian JK; Velarde N; Minasyan A; Albert R; Torres C; Romaneschi N; Johnston C; Tiwari S; Lee AS; Taylor AM; Gavériaux-Ruff C; Kieffer BL; Evans CJ; Cahill CM; Walwyn WM
    eNeuro; 2020; 7(5):. PubMed ID: 32859725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward.
    Reeves KC; Kube MJ; Grecco GG; Fritz BM; Muñoz B; Yin F; Gao Y; Haggerty DL; Hoffman HJ; Atwood BK
    Addict Biol; 2021 May; 26(3):e12942. PubMed ID: 32686251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. μ-Opioid receptors within subregions of the striatum mediate pair bond formation through parallel yet distinct reward mechanisms.
    Resendez SL; Dome M; Gormley G; Franco D; Nevárez N; Hamid AA; Aragona BJ
    J Neurosci; 2013 May; 33(21):9140-9. PubMed ID: 23699524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust age, but limited sex, differences in mu-opioid receptors in the rat brain: relevance for reward and drug-seeking behaviors in juveniles.
    Smith CJW; Ratnaseelan AM; Veenema AH
    Brain Struct Funct; 2018 Jan; 223(1):475-488. PubMed ID: 28871491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu opioid receptors in the medial habenula contribute to naloxone aversion.
    Boulos LJ; Ben Hamida S; Bailly J; Maitra M; Ehrlich AT; Gavériaux-Ruff C; Darcq E; Kieffer BL
    Neuropsychopharmacology; 2020 Jan; 45(2):247-255. PubMed ID: 31005059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and pain.
    Cuitavi J; Torres-Pérez JV; Lorente JD; Campos-Jurado Y; Andrés-Herrera P; Polache A; Agustín-Pavón C; Hipólito L
    Neurosci Biobehav Rev; 2023 Feb; 145():105011. PubMed ID: 36565942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies toward safer mu opioid receptor drugs for pain management.
    Ehrlich AT; Kieffer BL; Darcq E
    Expert Opin Ther Targets; 2019 Apr; 23(4):315-326. PubMed ID: 30802415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome.
    Baldo BA
    Curr Res Toxicol; 2022; 3():100078. PubMed ID: 35734228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
    Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND
    PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Curr Drug Abuse Rev; 2008 Jun; 1(2):222-38. PubMed ID: 19630721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
    Lutz PE; Ayranci G; Chu-Sin-Chung P; Matifas A; Koebel P; Filliol D; Befort K; Ouagazzal AM; Kieffer BL
    Neuropsychopharmacology; 2014 Oct; 39(11):2694-705. PubMed ID: 24874714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.
    Meier IM; Eikemo M; Leknes S
    Curr Addict Rep; 2021; 8(2):306-318. PubMed ID: 34722114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.
    Fox PD; Hentges ST
    J Neurosci; 2017 Sep; 37(36):8667-8677. PubMed ID: 28821664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.